Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Current Assets (2017 - 2025)

Historic Current Assets for Inspire Medical Systems (INSP) over the last 9 years, with Q4 2025 value amounting to $583.7 million.

  • Inspire Medical Systems' Current Assets fell 747.52% to $583.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $583.7 million, marking a year-over-year decrease of 747.52%. This contributed to the annual value of $583.7 million for FY2025, which is 747.52% down from last year.
  • Latest data reveals that Inspire Medical Systems reported Current Assets of $583.7 million as of Q4 2025, which was down 747.52% from $586.5 million recorded in Q3 2025.
  • In the past 5 years, Inspire Medical Systems' Current Assets ranged from a high of $630.8 million in Q4 2024 and a low of $249.5 million during Q2 2021
  • Its 5-year average for Current Assets is $477.5 million, with a median of $564.8 million in 2023.
  • Per our database at Business Quant, Inspire Medical Systems' Current Assets surged by 11284.9% in 2023 and then crashed by 747.52% in 2025.
  • Quarter analysis of 5 years shows Inspire Medical Systems' Current Assets stood at $268.5 million in 2021, then soared by 97.38% to $530.0 million in 2022, then rose by 12.02% to $593.7 million in 2023, then rose by 6.24% to $630.8 million in 2024, then fell by 7.48% to $583.7 million in 2025.
  • Its Current Assets stands at $583.7 million for Q4 2025, versus $586.5 million for Q3 2025 and $573.2 million for Q2 2025.